During metabolic syndrome progression, the highly pro-inflammatory microenvironment is typically maintained by the constant release of abnormal cytokines levels including IL-1β, TNF-α, IL-6 and, acute phase proteins, which strongly contribute to the metabolic failure of metabolically active organs such as liver (88). The gene discussed is IL1B; the disease is metabolic syndrome.